Novo's Wegovy is significantly expanding the obesity treatment market, given its strong efficacy, and is poised to remain a key drug in the market until patent expiration in 2032.

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...